Each of the members of the Supervisory Board and Managing Board has tendered or will tender all of their QIAGEN shares in the offer. and VENLO, The Netherlands – July 16, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.The members of QIAGEN’s Supervisory Board and Managing Board have reaffirmed their unanimous support for the offer and their unanimous recommendation that all QIAGEN shareholders accept and tender all of their QIAGEN shares in the offer prior to the end of the acceptance period, which has now been extended to August 10, 2020. The terms and conditions of the tender offer are published in, and the offer to purchase ordinary shares of QIAGEN is made only pursuant to, the offer document as permitted for publication … Unauthorized distribution, transmission or republication strictly prohibited.“PSquared will not tender any shares into the current offer.”Hedge fund Davidson Kempner, which says it owns more than 5% of Qiagen, a day earlier said it would not tender its shares into the offer, adding a price of between 48 euros and 52 euros a share was more appropriate. The Tender Offer is subject to certain customary closing conditions, including, among others, the receipt of applicable regulatory approvals, the adoption of certain resolutions relating to the transaction at QIAGEN's general meeting of shareholders (the "General Meeting"), and a minimum acceptance threshold of at least 75% of QIAGEN's issued and outstanding ordinary share capital as of the end of the … The QIAGEN Managing Board and Supervisory Board have unanimously recommended that QIAGEN shareholders accept the Tender Offer by tendering their shares and vote in favor of each … The terms and conditions of the tender offer will be published in, and the offer to purchase ordinary shares of QIAGEN will be made only pursuant to, the offer document and related offer … The terms and conditions of the tender offer are published in, and the offer to purchase ordinary shares of QIAGEN is made only pursuant to, the offer document, the publication of which was permitted by German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht), and related offer … “PSquared believes that the current cash offer by Thermo Fisher at 43 euros ($50.45) per share materially undervalues Qiagen on a standalone basis,” the fund said in response to a Reuters request.© 2020 Financial Post, a division of Postmedia Network Inc. All rights reserved.
Rent To Own Homes In Canyon Lake, Tx, South Table Mountain, Snapdragon 855 Plus Vs 865, Germantown Nashville Tornado, Randy Kovitz Workshop, Rubicon Meaning Jeep, Moto G8 Plus Unlocked, Amd Opteron 6386, Peppermint Coca Cola, Casa Jalisco Menu Alexandria Mn, Aak International Linkedin, West Ham Away Shirt, Home Of The Hittaz Youtube, Nokia Solutions And Networks Salary, Ryzen 3 3200G Benchmark, Cheap Sports Bars Downtown Toronto, Chennai Weather Satellite, Icbc Ceo Email, Hang Seng Futures, Aak International Linkedin, Ed Harris 2019, Single Crochet Increase Magic Ring, Map Of Chattanooga Area, Lakers Starting Lineup Tonight, Medina Tornado 2020, Lennie Tristano Cool Jazz, Steven Brault Instagram, Atlanta Beat Band, Hope Mills Power Outage, Bristol To Bath University, Kel Mitchell Net Worth, Philips Stock Dividend, Pittsburgh Sweatshirt Juju, Father's Day 2012, Arizona Highway 88 Road Conditions, Amanda Leatherman Date Of Birth, Sams Club Duracell Car Battery Warranty, Tofutti Sour Cream Recipes, Samsung M Series Model List, Boc Hk Share Price 2388, Glam Party Themes, Sju Bookstore Phone Number, Izettle App Store, Japanese Fridge Open Both Sides, 25 Hill Full Movie, Brett Harrelson Cbd, 10 Micron To Mm,
